Tenet Healthcare Corporation
THC
$124.82
-$1.20-0.95%
| Weiss Ratings | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B+ | |||
| Rating Factors | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.20 | |||
| Price History | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.22% | |||
| 30-Day Total Return | -7.11% | |||
| 60-Day Total Return | -10.11% | |||
| 90-Day Total Return | -20.78% | |||
| Year to Date Total Return | -0.29% | |||
| 1-Year Total Return | 28.27% | |||
| 2-Year Total Return | 108.73% | |||
| 3-Year Total Return | 43.30% | |||
| 5-Year Total Return | 383.02% | |||
| 52-Week High % Change | -26.39% | |||
| 52-Week Low % Change | 39.98% | |||
| Price | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $171.20 | |||
| 52-Week Low Price | $90.03 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Sep 23, 2024 | |||
| Valuation | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.99B | |||
| Enterprise Value | 27.62B | |||
| Price/Earnings (TTM) | 3.91 | |||
| Earnings Per Share (TTM) | 32.22 | |||
| Earnings Per Share Growth | 464.44% | |||
| Price/Earnings To Growth | 0.01 | |||
| Price/Sales (TTM) | 0.58 | |||
| Price/Book (Q) | 2.87 | |||
| Enterprise Value/Revenue (TTM) | 1.34 | |||
| Price | $124.86 | |||
| Enterprise Value/EBITDA (TTM) | 5.65 | |||
| Enterprise Value/EBIT | 7.12 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 95.88M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 469 893 2200 | |||
| Address | 14201 Dallas Parkway Dallas, TX 75254 | |||
| Website | www.tenethealth.com | |||
| Country | United States | |||
| Year Founded | 1967 | |||
| Profitability | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 18.78% | |||
| Profit Margin | 15.48% | |||
| Management Effectiveness | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.47% | |||
| Return on Equity | 57.83% | |||
| Income Statement | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.67B | |||
| Total Revenue (TTM) | 20.67B | |||
| Revenue Per Share | $215.53 | |||
| Gross Profit (TTM) | 8.21B | |||
| EBITDA (TTM) | 4.89B | |||
| EBIT (TTM) | 3.88B | |||
| Net Income (TTM) | 3.20B | |||
| Net Income Avl. to Common (TTM) | 3.20B | |||
| Total Revenue Growth (Q YOY) | -5.71% | |||
| Earnings Growth (Q YOY) | 25.44% | |||
| EPS Diluted (TTM) | 32.22 | |||
| EPS Diluted Growth (Q YOY) | 43.49% | |||
| Balance Sheet | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.02B | |||
| Cash Per Share (Q) | $31.49 | |||
| Total Current Assets (Q) | 7.68B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 8.55B | |||
| Current Ratio (Q) | 1.782 | |||
| Book Value Per Share (Q) | $43.85 | |||
| Total Assets (Q) | 28.94B | |||
| Total Current Liabilities (Q) | 4.31B | |||
| Total Debt (Q) | 14.33B | |||
| Total Liabilities (Q) | 20.39B | |||
| Total Common Equity (Q) | 4.17B | |||
| Cash Flow | THC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 3.43B | |||
| Cash from Financing (TTM) | -3.69B | |||
| Net Change in Cash (TTM) | 1.79B | |||
| Levered Free Cash Flow (TTM) | 1.07B | |||
| Cash from Operations (TTM) | 2.05B | |||
